Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Acetrizoic Acid
2. Acid, Acetrizoic
3. Jodopax
4. Salpix
5. Sodium, Acetrizoate
6. Triiotrast
7. Visotrast 300
8. Visotrast 400
1. Sodium Acetrizoate
2. Salpix
3. Diaginol
4. Reopak
5. 129-63-5
6. Sodium 3-acetamido-2,4,6-triiodobenzoate
7. Acetiodon
8. Mp 1023
9. Acetrizoic Acid Sodium Salt
10. Sodium Acetrizoate [inn]
11. 5gf4b2i1dd
12. Bronchoselectan
13. Cystokon
14. Iodopact
15. Iodopaque
16. Jodopax
17. Thixokon
18. Triiodyl
19. Triiotrast
20. Triopac
21. Triopas
22. Triumbren
23. Triurol
24. Triuropan
25. Vesamin
26. Benzoic Acid, 3-(acetamido)-2,4,6-triiodo-, Monosodium Salt
27. Sodium Urokon
28. Tri-abrodil
29. Fortombrine-n
30. Urokon Sodium
31. Pyelokon-r
32. Acidum Acetrizoicum
33. Acetrizoate Sodium Salt
34. Triopac 200
35. Natrii Acetrizoas
36. Acetrizoato Sodico
37. Acetrizoato Sodico [dcit]
38. Acetrizoate De Sodium
39. Natrii Acetrizoas [inn-latin]
40. Acetrizoate De Sodium [inn-french]
41. Einecs 204-956-1
42. Acetrizoate Sodium [usp]
43. Unii-5gf4b2i1dd
44. Sodiumacetrizoate
45. Sodium 3-acetylamino-2,4,6-triiodobenzoate
46. 3-acetamido-2,4,6-triiodobenzoic Acid Sodium Salt
47. 2,4,6-trijod-3-acetaminobenzosaeure Natrium [german]
48. 2,4,6-trijod-3-acetaminobenzosaeure Natrium
49. Schembl468513
50. Dtxsid30926269
51. Sodium Acetrizoate [mart.]
52. Sodium Acetrizoate [who-dd]
53. Benzoic Acid, 3-acetamido-2,4,6-triiodo-, Monosodium Salt
54. Mp1023
55. Mp-1023
56. Acetrizoate Sodium [orange Book]
57. Acetrizoic Acid Sodium Salt [mi]
58. Sodium;3-acetamido-2,4,6-triiodobenzoate
59. Q7553295
Molecular Weight | 578.84 g/mol |
---|---|
Molecular Formula | C9H5I3NNaO3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 578.7301 g/mol |
Monoisotopic Mass | 578.7301 g/mol |
Topological Polar Surface Area | 69.2 Ų |
Heavy Atom Count | 17 |
Formal Charge | 0 |
Complexity | 305 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
ABOUT THIS PAGE
75
PharmaCompass offers a list of Acetrizoic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Acetrizoic Acid manufacturer or Acetrizoic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Acetrizoic Acid manufacturer or Acetrizoic Acid supplier.
PharmaCompass also assists you with knowing the Acetrizoic Acid API Price utilized in the formulation of products. Acetrizoic Acid API Price is not always fixed or binding as the Acetrizoic Acid Price is obtained through a variety of data sources. The Acetrizoic Acid Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Triopas manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Triopas, including repackagers and relabelers. The FDA regulates Triopas manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Triopas API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Triopas supplier is an individual or a company that provides Triopas active pharmaceutical ingredient (API) or Triopas finished formulations upon request. The Triopas suppliers may include Triopas API manufacturers, exporters, distributors and traders.
click here to find a list of Triopas suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Triopas DMF (Drug Master File) is a document detailing the whole manufacturing process of Triopas active pharmaceutical ingredient (API) in detail. Different forms of Triopas DMFs exist exist since differing nations have different regulations, such as Triopas USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Triopas DMF submitted to regulatory agencies in the US is known as a USDMF. Triopas USDMF includes data on Triopas's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Triopas USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Triopas suppliers with USDMF on PharmaCompass.
Triopas Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Triopas GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Triopas GMP manufacturer or Triopas GMP API supplier for your needs.
A Triopas CoA (Certificate of Analysis) is a formal document that attests to Triopas's compliance with Triopas specifications and serves as a tool for batch-level quality control.
Triopas CoA mostly includes findings from lab analyses of a specific batch. For each Triopas CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Triopas may be tested according to a variety of international standards, such as European Pharmacopoeia (Triopas EP), Triopas JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Triopas USP).